|
|
Volumn 6, Issue 2, 2000, Pages 185-190
|
|
Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
GANCICLOVIR;
INTERLEUKIN 2;
THYMIDINE KINASE;
ANIMAL;
ARTICLE;
CANCER TRANSPLANTATION;
CELL CULTURE;
CYTOTOXICITY;
FEMALE;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETIC ENGINEERING;
GENETIC TRANSFECTION;
GENETICS;
HERPES SIMPLEX VIRUS;
HUMAN;
IMMUNOLOGY;
INTRAPERITONEAL DRUG ADMINISTRATION;
MALE;
METABOLISM;
MOUSE;
MULTIMODALITY CANCER THERAPY;
NORTHERN BLOTTING;
OVARY TUMOR;
ANIMALS;
ANTIVIRAL AGENTS;
BLOTTING, NORTHERN;
COMBINED MODALITY THERAPY;
CYTOTOXICITY, IMMUNOLOGIC;
FEMALE;
GANCICLOVIR;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
GENETIC ENGINEERING;
HUMANS;
INJECTIONS, INTRAPERITONEAL;
INTERLEUKIN-2;
MALE;
MICE;
NEOPLASM TRANSPLANTATION;
OVARIAN NEOPLASMS;
SIMPLEXVIRUS;
THYMIDINE KINASE;
TRANSFECTION;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
|
EID: 0034241504
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.6.2.185 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
